9 insiders reported 11 Form 4 transactions for Barinthus Biotherapeutics plc. (BRNS) over the past 18 months (most recent 2026-09-11). Recent activity: Oxford Science Enterprises plc (Insider) Sell 8.8M shares, DAWES KAREN A (Director) Sell 1,700 shares, Phillips Anne M. (Director) Sell 3,000 shares, Enright William (Chief Executive Officer) Sell 728,454 shares, Hammacher Alex (Director) Sell 3,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Oxford Science Enterprises plc | Insider | Sell | 8.8M | $976,552 |
| 2026-09-09 | DAWES KAREN A | Director | Sell | 1,700 | $0 |
| 2026-09-09 | Phillips Anne M. | Director | Sell | 3,000 | $0 |
| 2026-09-09 | Enright William | Chief Executive Officer | Sell | 728,454 | $0 |
| 2026-09-09 | Hammacher Alex | Director | Sell | 3,000 | $0 |
| 2026-09-09 | Morgon Pierre A. | Director | Sell | 10,506 | $0 |
| 2026-09-09 | Wright Robin | Director | Sell | 48,256 | $0 |
| 2026-09-09 | Scheeren Joseph | Director | Sell | 23,000 | $0 |
| 2026-09-09 | Hooftman Leon | Chief Medical Officer | Buy | 361,530 | $0 |
| 2026-09-09 | Enright William | Chief Executive Officer | Sell | 514,923 | $0 |
| 2026-09-09 | Hooftman Leon | Chief Medical Officer | Sell | 361,530 | $0 |
Source: SEC Form 4 filings · as of 2026-09-11